Haema and BPC, two businesses Grifols acquired in 2018, are owned by Scranton Enterprises BV, an investment vehicle controlled by former company executives, including family members. Gotham said ...

Grifols said the loan was disclosed in regulatory filings, including its annual report for the year ended Dec. 31, 2018. Bloomberg News reported on Jan. 19 that Scranton Enterprises was asked by ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

where Rigel secured approval for the drug as Tavalisse in 2018. It was the first non-plasma product that the Grifols' flagship bioscience division launched in the European market. Grifols has been ...